|Application ||WB, E|
|Calculated MW||63747 Da|
|Other Names||Tumor necrosis factor receptor superfamily member 8, CD30L receptor, Ki-1 antigen, Lymphocyte activation antigen CD30, CD30, TNFRSF8, CD30, D1S166E|
|Target/Specificity||This TNFRSF8/CD30 antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 294-321 amino acids from the Central region of human TNFRSF8/CD30.|
|Format||Mouse monoclonal antibody supplied in crude ascites with 0.09% (W/V) sodium azide.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||TNFRSF8/CD30 Antibody (Center) (Ascites) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF- kappa-B.|
|Cellular Location||Isoform 1: Cell membrane; Single-pass type I membrane protein|
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.
de Kleer, I., et al. J. Immunol. 185(4):2071-2079(2010)
Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :
Halim, M.A., et al. Transplant. Proc. 42(3):801-803(2010)
Dong, L., et al. J. Biomed. Biotechnol. 2010, 569053 (2010) :
Kamali, K., et al. Exp Clin Transplant 7(4):237-240(2009)